Bladder cancer study tracks mood swings during standard therapy
NCT ID NCT05672615
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the standard BCG treatment for non-muscle invasive bladder cancer may affect patients' mood. Researchers will collect urine and blood samples to measure immune responses, and participants will fill out mood questionnaires and daily diaries. The goal is to better understand any emotional changes during treatment, not to test a new drug or therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sibley Memorial Hospital
RECRUITINGWashington D.C., District of Columbia, 20016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bag-Like device pull bladder tumors out whole?
- Could a simple blood or urine test spot bladder cancer earlier?
- Can heated chemotherapy beat bladder cancer without surgery?
- Can a Two-Drug bladder wash beat cancer recurrence?
- Bladder cancer surgery: what happens after the bladder is removed?
- AI eye on bladder cancer: could a smart navigation system help surgeons remove tumors more completely?